Basal Cell Carcinoma

Treatment Options and Prognosis, a Scientific Approach to a Common Malignancy

Abstract

The incidence of basal cell carcinoma is rapidly increasing and a number of treatment modalities are available. Treatment of basal cell carcinoma includes both surgical and nonsurgical approaches, some of which are traditional, and others experimental. The treatment modality utilized is dependent on both the tumor type and the patient.

In order to choose between therapies, evidence-based research is necessary. In an extensive review of the literature concerning treatment options for patients with basal cell carcinoma, we found that there are a limited number of comparative, prospective, randomized, long-term follow-up studies. Based on the results of the available studies, surgical excision, Mohs surgery and cryosurgery are the three standard therapies of choice. Other treatment modalities should be considered secondary choices. There are also promising new treatment options, such as photodynamic therapy, which need further investigation.

Special attention is needed when treating the more aggressive subtypes of the disease, such as the micronodular, infiltrative, adenoid and morpheic forms of basal cell carcinoma, as well as bigger basal cell carcinomas and basal cell carcinoma recurrences.

This is a preview of subscription content, access via your institution.

Table I
Fig. 1
Table II
Table III
Fig. 2
Table IV
Table V
Fig. 3

References

  1. 1.

    Thissen M.R., Neumann H.A.M., Berretty P.J.M., et al. De behandeling van patienten met basalecelcarcinomen door dermatologen in Nederland. Ned Tijdschr Geneeskd 1998; 142: 1563–1567

    PubMed  CAS  Google Scholar 

  2. 2.

    Telfer N.R., Colver G.B., Bowers P.W. Guidelines for the management of basal cell carcinoma. Br J Dermatol 1999; 141: 415–423

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Motley R.J. The treatment of basal cell carcinoma. J Dermatol Treat 1995; 6: 121–125

    Article  Google Scholar 

  4. 4.

    Wade T.R., Ackerman A.B. The many faces of basal cell carcinoma. J Dermatol Surg Oncol 1978; 4: 23–28

    PubMed  CAS  Google Scholar 

  5. 5.

    Rippey J.J. Why classify basal cell carcinomas? Histopathology 1998; 32: 393–398

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Emmett A.J. Surgical analysis and biological behaviour of 2277 basal cell carcinomas. Aust N Z J Surg 1990; 60 (11): 855–863

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Krekels G.A.M. Basal cell carcinoma, a disease on the increase: implications for treatment and prevention [thesis]. Maastricht: University of Masstricht, 1998

    Google Scholar 

  8. 8.

    Leffell D.J., Headington J.T., Wong D.S., et al. Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol 1991; 127: 1663–1667

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Kopf A.W. Computer analysis of 3531 basal cell carcinomas of the skin. J Dermatol 1979; 6: 267–281

    PubMed  CAS  Google Scholar 

  10. 10.

    Bastiaans M.T., Hoefnagel J.J., Bruijn J.A., et al. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinomas indicate different types of tumors. J Invest Dermatol 1998; 110: 880–884

    Article  Google Scholar 

  11. 11.

    McCormack C.J., Kelly J.W., Dorevitch A.P. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma: a possible indicator of different causes. Arch Dermatol 1997; 133: 593–596

    PubMed  Article  CAS  Google Scholar 

  12. 12.

    Salasche S.J., Amonette R. Morpheaform basal-cell epitheliomas: a study of subclinical extensions in a series of 51 cases. J Dermatol Surg Oncol 1981; 7: 387–392

    PubMed  CAS  Google Scholar 

  13. 13.

    Lo J.S., Snow S.N., Reizner G.T., et al. Metastatic basal cell carcinoma report of twelve cases with cases with a review of the literature. J Am Acad Dermatol 1991; 24: 715–719

    Article  Google Scholar 

  14. 14.

    Pinkus H. Epithelial and fibroepithelial tumors. Arch Dermatol 1965; 91: 24–37

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Hendrix J.D., Parlette H.L. Micronodular basal cell carcinoma: a deceptive histologic subtype with frequent clinically undetected tumor extension. Arch Dermatol 1996; 132: 295–298

    PubMed  Article  Google Scholar 

  16. 16.

    Germann G., Bernstein-Sommer B., Petrovici V., et al. Differenzierte, onkologisch adäquate therapie des basalioms. Handchir Mikrochir Plast Chir 1992; 24 (3): 151–158

    PubMed  CAS  Google Scholar 

  17. 17.

    Miller P.K., Roenigk R.K., Brodland D.G., et al. Cutaneous micrographic surgery: Mohs procedure. Mayo Clin Proc 1992; 67: 971–980

    PubMed  CAS  Google Scholar 

  18. 18.

    Swanson N.A. Mohs surgery: technique, indications, applications, and the future. Arch Dermatol 1983; 19: 761–773

    Article  Google Scholar 

  19. 19.

    Mohs F.E., Lahtrop T.G. Modes of spread of cancer of skin. Arch Dermatol 1952; 66: 427–439

    Article  CAS  Google Scholar 

  20. 20.

    Mark G.J. Basal cell carcinoma with intraneural invasion. Cancer 1977; 40: 2181–2187

    PubMed  Article  CAS  Google Scholar 

  21. 21.

    Ratner D., Lowe L., Johnson T.M., et al. Perineural spread of basal cell carcinomas treated with mohs micrographic surgery. Cancer 2000; 88 (7): 1605–1613

    PubMed  Article  CAS  Google Scholar 

  22. 22.

    Neumann H.A.M. Behandeling van maligne epidermale tumoren, een strategie. Ned Tijdschr voor Dermatol Venereol 1996; 6: 250–256

    Google Scholar 

  23. 23.

    Mosely H., Mackie R.M. Ultraviolet B radiation was increased at ground level in Scotland during a period of ozone depletion. Br J Dermatol 1997; 137: 101–102

    Article  Google Scholar 

  24. 24.

    Miller D.L., Weinstock M.A. Nonmelanoma skin cancer in the United States; incidence. J Am Acad Dermatol 1994; 30: 774–778

    PubMed  Article  CAS  Google Scholar 

  25. 25.

    Armstrong B.K., Kricker A. Skin cancer. Dermatol Clin 1995; 13: 583–594

    PubMed  CAS  Google Scholar 

  26. 26.

    Asada M., Schaart F.M., De Almeida H.L., et al. Solid basal cell carcinoma possibly originates from the outer root sheath of the hair follicle. Acta Derm Venereol 1993; 73: 286–292

    PubMed  CAS  Google Scholar 

  27. 27.

    Wei Q., Matanoski G.M., Farmer E.R., et al. DNA repair and ageing in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci USA 1993; 90: 1614–1618

    PubMed  Article  CAS  Google Scholar 

  28. 28.

    Verhaegh M.E.J.M., Sanders C.J.G., Arends J.W., et al. Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer. Br J Dermatol 1995; 132: 740–744

    PubMed  Article  CAS  Google Scholar 

  29. 29.

    Wilkonkal N.M., Berg R.J.W., van Haselen C.W., et al. Bcl-2 vs p53 protein expression and apoptotic rate in human nonmelanoma skin cancers. Arch Dermatol 1997; 133: 599–602

    Article  Google Scholar 

  30. 30.

    Goldberg L.H. Basal cell carcinoma. Lancet 1996; 347: 663–667

    PubMed  Article  CAS  Google Scholar 

  31. 31.

    Naldi L., DiLandro A., D’Avanzo B., et al. Host-related and environmental risk factors for cutaneous basal cell carcinoma: evidence from an Italian case-control study. J Am Acad Dermatol 2000; 42: 446–452

    PubMed  Article  CAS  Google Scholar 

  32. 32.

    Kimonis V.E., Goldstein A.M., Pastakia B., et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997; 69: 299–308

    PubMed  Article  CAS  Google Scholar 

  33. 33.

    Gorlin R. Nevoid basal cell carcinoma syndrome. Dermatol Clin 1995; 13: 113–125

    PubMed  CAS  Google Scholar 

  34. 34.

    Grossman L., Wei Q. DNA repair and epidemiology of basal cell carcinoma. Clin Chem 1995; 41: 1854–1863

    PubMed  CAS  Google Scholar 

  35. 35.

    Shannon R.L., Strayer D.S. Arsenic induced skin toxicity. Human Toxicol 1989; 113: 99–104

    Article  Google Scholar 

  36. 36.

    Lang Jr PG, editor. Variables to consider in the management of non-melanoma skin cancer. J Geriatr Dermatol 1996; 4: 231-237

  37. 37.

    Silverman M.K., Kopf A.W., Grin C.M., et al. Recurrence rates of treated basal cell carcinomas, Part 3: surgical excision. J Dermatol Surg Oncol 1992; 18 (6): 471–476

    PubMed  CAS  Google Scholar 

  38. 38.

    Rowe D.E., Carrol R.J., Day C.L. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient and follow-up. J Dermatol Surg Oncol 1989; 15: 315–320

    PubMed  CAS  Google Scholar 

  39. 39.

    Silverman M.K., Kopf A.W., Grin C.M., et al. Recurrence rates of treated basal cell carcinomas, Part 4: X-ray therapy. J Dermatol Surg Oncol 1992; 18 (7): 549–554

    PubMed  CAS  Google Scholar 

  40. 40.

    Silverman M.K., Kopf A.W., Grin C.M., et al. Recurrence rates of treated basal cell carcinomas; part 2: curettage-electrodessication. J Dermatol Surg Oncol 1991; 17 (9): 720–726

    PubMed  CAS  Google Scholar 

  41. 41.

    Soler A.M., Warloe T., Tausjo J., et al. Photodynamic therapy by topical aminolevulenic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol 1999; 79: 204–206

    PubMed  Article  CAS  Google Scholar 

  42. 42.

    Fink-Puches R., Soyer H.P., Hofer A., et al. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical d- aminolevulinic acid photodynamic therapy. Arch Dermatol 1998; 134: 821–826

    PubMed  Article  CAS  Google Scholar 

  43. 43.

    Thissen M.R., Neumann H.A., Schouten L.J. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999; 135: 1177–1183

    PubMed  Article  CAS  Google Scholar 

  44. 44.

    Breuninger H., Dietz K. Prediction of subclinical tumor infiltration in basal cell carcinoma. J Dermatol Surg Oncol 1991; 17: 574–578

    PubMed  CAS  Google Scholar 

  45. 45.

    Breuninger H., Rassner G., Undeutsch W. Operative behandlung von basaliomen mit errechnetem sicherheitsabstand und histologischer randcontrolle. Hautarzt 1984; 35: 303–307

    PubMed  CAS  Google Scholar 

  46. 46.

    Wolf D.J., Zitelli J.A. Surgical margins for basal cell carcinoma. Arch Dermatol 1987; 123: 340–344

    PubMed  Article  CAS  Google Scholar 

  47. 47.

    Neumann H.A. Approach to the oncological patient. In: Beljaards R.C., Neumann H.A., editors. Oncological dermatosurgery. Maastricht: University of Maastricht, 1996: 135–146

    Google Scholar 

  48. 48.

    Kooy A.J., Tank B., Jong de T.A., et al. Expression of cytokeratin 8 in basal cell carcinoma: a comparative immumohistochemical and immunoelectron microscopy study. Anticancer Res 1996; 16: 277–282

    PubMed  CAS  Google Scholar 

  49. 49.

    Thissen M.R.T.M., Neumann H.A.M. The sense and non-sense of immunohistochemical staining in basal cell carcinomas and other cutaneous tumors. Skin Cancer 1997; 12: 37–42

    Article  Google Scholar 

  50. 50.

    Abide J.M., Nahai F., Bennet R.G. The meaning of surgical margins. Plast Reconstr Surg 1984; 73: 492–496

    PubMed  Article  CAS  Google Scholar 

  51. 51.

    Dellon A.L., DeSilva S., Connolly M., et al. Prediction of recurrence in incompletely excised basal cell carcinoma. Plast Reconstr Surg 1985; 75: 860–871

    PubMed  Article  CAS  Google Scholar 

  52. 52.

    Richmond J.D., Davie R.M. The significance of incomplete excision in patients with basal cell carcinoma. Br J Plast Surg 1887; 40: 63–67

    Article  Google Scholar 

  53. 53.

    Robinson J.K., Fisher S.G. Recurrent basal cell carcinoma after incomplete resection. Arch Dermatol 2000; 136: 1318–1324

    PubMed  Article  CAS  Google Scholar 

  54. 54.

    Bieley H.C., Kirsner R.S., Reyes B.A., et al. The use of Mohs micrographic surgery for determination of residual tumor in incompletely excised basal cell carcinoma. J Am Acad Dermatol 1992; 26: 754–756

    PubMed  Article  CAS  Google Scholar 

  55. 55.

    Thissen M.R.T.M. Treatment of basal cell carcinoma in the light of photodynamic therapy [thesis]. Maastricht: University of Maastricht, 2000

    Google Scholar 

  56. 56.

    Krekels G.A.M., Verhaegh M.E.J.M., Neumann H.A.M. Mohs’ micrografische chirurgie. Ned Tijdschr Dermatol Venereol 1996; 6: 90–93

    Google Scholar 

  57. 57.

    Sakura C.Y., Calamel P.M. Comparison of treatment modalities for recurrent basal cell carcinoma. Plast Reconstr Surg 1979; 63 (4): 492–496

    PubMed  Article  CAS  Google Scholar 

  58. 58.

    Bauer M., Loosli R.M., Anderl H., et al. Operative behandlung maligner epitheliome der haut: grundsätze, methoden, ergebnisse. Chirurg 1977; 48: 170–179

    PubMed  CAS  Google Scholar 

  59. 59.

    Thissen M.R.T.M., Nieman F.H.M., Ideler A.H.L.B., et al. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 2000; 26 (8): 759–764

    PubMed  Article  CAS  Google Scholar 

  60. 60.

    Mohs F.E. Chemosurgery: microscopically controlled method of cancer excision. Arch Surg 1941; 42: 279–295

    Article  CAS  Google Scholar 

  61. 61.

    Julian C.G., Bowers P.W. A prospective study of Mohs’ micrographic surgery in two English centres. Br J Dermatol 1997; 136: 515–518

    PubMed  Article  CAS  Google Scholar 

  62. 62.

    Rowe D.E., Carroll R.J., Day C.L. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15: 424–431

    PubMed  CAS  Google Scholar 

  63. 63.

    Mohs F., Larson P., Iriondo M. Micrographic surgery for the microscopically controlled excision of carcinoma of the external ear. J Am Acad Dermatol 1988; 19 (4): 729–737

    PubMed  Article  CAS  Google Scholar 

  64. 64.

    Mohs F.E. Micrographic surgery for the microscopically controlled excision of eyelid cancers. Arch Ophthalmol 1986; 104 (6): 901–909

    PubMed  Article  CAS  Google Scholar 

  65. 65.

    Cook J., Zitelli J.A. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 1998; 39: 698–703

    PubMed  Article  CAS  Google Scholar 

  66. 66.

    Breuninger H., Holzschuh J. Die luckenlose histologische darstellung der schnittrander eines hauttumorexisates (3D-Histologie) in einer Schnittebene mittels der “Flundertechnik”. Akt Dermatol 1994; 20: 7–10

    Google Scholar 

  67. 67.

    Fernando L., Kopke F., Konz B. Mikrographische chirurgie: eine methodische bestandsaufnahme. Hautarzt 1995; 46: 607–614

    Article  Google Scholar 

  68. 68.

    Cooper I.S. Cryogenic surgery: a new method of destruction or extirpation of benign or malignant tissues. N Engl J Med 1963; 268: 743

    Article  Google Scholar 

  69. 69.

    Zacarian S.A. Cryosurgery for skin cancer. In: Zacarian S.A., editor. Cryosurgery for skin cancers and cutaneous disorders. St Louis (MO): CV Mosby, 1985: 96–162

    Google Scholar 

  70. 70.

    Fraunfelder F.T., Zacarian S.A., Wingfield D.L., et al. Results of cryotherapy for eyelid malignancies. Am J Ophtalmol 1984; 97: 184–188

    CAS  Google Scholar 

  71. 71.

    Torre D. Cryosurgical instrumentation and depth dose monitoring. In: Breithart E., Dachow-Siwiec E., editors. Clinics in dermatology: advances in cryosurgery. New York: Elsevier, 1990: 59

    Google Scholar 

  72. 72.

    Nordin P., Larko O., Stenquist B. Five-year results of curettage-cryosurgery of selected large primary basal cell carcinomas on the nose: an alternative treatment in a geographical area underserved by Mohs’ surgery. Br J Dermatol 1997; 136: 180–183

    PubMed  Article  CAS  Google Scholar 

  73. 73.

    Lindren G., Larko O. Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. J Am Acad Dermatol 1997; 36: 742–746

    Article  Google Scholar 

  74. 74.

    Anders M., Sport E., Kranz H., et al. Kryotherapie von malignen lidtumoren. Ophthalmologe 1995; 92: 78–92

    Google Scholar 

  75. 75.

    Kopf A.W., Bart R.S., Lazar M., et al. Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 1977; 113 (4): 439–443

    PubMed  Article  CAS  Google Scholar 

  76. 76.

    Caccialanza M., Piccinno R., Beretta M., et al. Results and side effects of dermatologic radiotherapy: a retrospective study of irradiated cutaneous epithelial neoplasms. J Am Acad Dermatol 1999; 41 (4): 590–594

    Google Scholar 

  77. 77.

    Reymann F., Kopp H. Treatment of basal cell carcinoma of the skin with ultrasoft X-rays. Dermatologica 1978; 156 (1): 40–47

    PubMed  Article  CAS  Google Scholar 

  78. 78.

    Schneiter M., Krebs A. Therapeutische funktionell und kosmetische spätergebnisse von 103 patienten mit mittels weichstrahltherapie behandelten 117 basaliomen. Dermatologica 1983; 165 (4): 342–351

    Article  Google Scholar 

  79. 79.

    Holmes M.E., Bomford C.K., Phil M. The use of a short distance cobalt unit in the treatment of primary skin tumors. Br J Radiol 1982; 55: 225–228

    PubMed  Article  CAS  Google Scholar 

  80. 80.

    Smith S.P., Grande D.J. Basal cell carcinoma recurring after radiotherapy: a unique, difficult treatment subclass of recurrent basal cell carcinoma. J Dermatol Surg Oncol 1991; 17: 26–30

    PubMed  CAS  Google Scholar 

  81. 81.

    Davis M.M., Hanke C.W., Zollinger T.W., et al. Skin cancer in patients with chronic radiation dermatitis. J Am Acad Dermatol 1989; 20: 608–616

    PubMed  Article  CAS  Google Scholar 

  82. 82.

    Beswick S.J., Garrido M.C., Fryer A.A., et al. Multiple basal cell carcinomas and malignant melanoma following radiotherapy for ankylosing spondylitis. Clin Exp Dermatol 2000; 25: 381–383

    PubMed  Article  CAS  Google Scholar 

  83. 83.

    Fritsch C., Goerz G., Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol 1998; 134: 207–214

    PubMed  Article  CAS  Google Scholar 

  84. 84.

    Lavie G., Kaplinsky C., Toren A., et al. A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy. Br J Cancer 1999; 79 (3/4): 423–432

    PubMed  Article  CAS  Google Scholar 

  85. 85.

    Svanberg K., Andersson T., Wang I., et al. Photodynamic therapy of non-melanoma malignant tumors of the skin using topical delta-amino levulenic acid sensitization and laser irradiation. Br J Dermatol 1994; 130: 743–751

    PubMed  Article  CAS  Google Scholar 

  86. 86.

    Wennberg A.M., Lindholm L.E., Alpsten M., et al. Treatment of superficial basal cell carcinomas using topically applied delta-aminolaevulinic acid and a filtered xenon lamp. Arch Dermatol Res 1996; 288: 561–564

    PubMed  Article  CAS  Google Scholar 

  87. 87.

    Morton C.A., MacKie R.M., Whitehurst C., et al. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 1998; 134: 248–249

    PubMed  Article  CAS  Google Scholar 

  88. 88.

    Robinson D.J., de Bruijn H.S., van der Veen N., et al. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin; the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol 1998; 67: 140–149

    PubMed  Article  CAS  Google Scholar 

  89. 89.

    Thissen M.R., Schroeter C.A., Neumann H.A.M. Photodynamic therapy with deltaaminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000; 142: 338–339

    PubMed  Article  CAS  Google Scholar 

  90. 90.

    Fritsch C., Neumann N.J., Ruzicka T., et al. Photodiagnostische testverfaren, Teil 3: fluoreszenzdiagnostik mit delta-aminolävulinsäure-induzierten porphyrinen (FDAP) in der dermatologie. Hautarzt 2000; 51: 528–545

    PubMed  Article  CAS  Google Scholar 

  91. 91.

    Wennberg A.M., Gudmundson F., Stenquist B., et al. In vivo detection of basal cell carcinoma using imaging spectroscopy. Acta Derm Venereol 1999; 79: 54–61

    PubMed  Article  CAS  Google Scholar 

  92. 92.

    Reymann F. Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment: a 10-year follow-up study. Dermatologica 1979; 158: 368–372

    PubMed  Article  CAS  Google Scholar 

  93. 93.

    Beuchner S.A. Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. J Am Acad Dermatol 1991; 24: 731–734

    Article  Google Scholar 

  94. 94.

    Boneschi V., Brambilla L., Chiappino G., et al. Intralesional alpha 2b recombinant interferon for basal cell carcinomas. Int J Dermatol 1991; 30 (3): 220–224

    PubMed  Article  CAS  Google Scholar 

  95. 95.

    Cornell R.C., Greenway H.T., Tucker S.B., et al. Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 1990; 23: 694–700

    PubMed  Article  CAS  Google Scholar 

  96. 96.

    Beutner K.R., Geisse J.K., Helman D., et al. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999; 41: 1002–1007

    PubMed  Article  CAS  Google Scholar 

  97. 97.

    Levine N. Role of retinoids in skin cancer treatment and prevention. J Am Acad Dermatol 1998; 39 (2 Pt 3): S62–S66

    PubMed  Article  CAS  Google Scholar 

  98. 98.

    Bigby M. Evidence-based medicine in a nutshell: a guide to finding and using the best evidence in caring for patients. Arch Dermatol 1998; 134: 1609–1618

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors received no funding for the preparation of this manuscript.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Dr Daniëlle I. M. Kuijpers.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kuijpers, D.I.M., Thissen, M.R.T.M. & Neumann, M.H.A. Basal Cell Carcinoma. Am J Clin Dermatol 3, 247–259 (2002). https://doi.org/10.2165/00128071-200203040-00003

Download citation

Keywords

  • Basal Cell Carcinoma
  • Aminolevulinic Acid
  • Seborrheic Keratosis
  • Basal Cell Nevus Syndrome
  • Superficial Basal Cell Carcinoma